Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Akiva P. Novetsky

A Phase II Trial of a Surgical Protocol to Decrease the Incidence of Wound Complications in Obese Gynecologic Oncology Patients

Gynecologic Oncology

English

Phase II Study of Bevacizumab and Pemetrexed for Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

English

Related publications

Phase II Trial of Nab-Paclitaxel in the Treatment of Recurrent or Persistent Advanced Cervix Cancer: A Gynecologic Oncology Group Study

English

Implementation of a Restrictive Blood Transfusion Protocol in a Gynecologic Oncology Service

Gynecology and Reproductive Endocrinology

2019

English

A Phase II Evaluation of Nintedanib (BIBF-1120) in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

English

516: Does the Alexis O-Ring Wound Retractor Decrease Surgical Blood Loss: A Secondary Analysis of a Randomized Controlled Trial

American Journal of Obstetrics and Gynecology

Gynecology

Obstetrics

2016

English

Supplemental Parenteral Nutrition in Critically Ill Patients: A Study Protocol for a Phase II Randomised Controlled Trial

English

A Phase II Evaluation of Lapatinib in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study

English

Access to Quality Gynecologic Oncology Care: A Work in Progress

English

Perioperative Hypothermia and Incidence of Surgical Wound Infection: A Bibliographic Study

Einstein (São Paulo, Brazil)

Medicine

2014

English

Phase II Evaluation of Dasatinib in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Akiva P. Novetsky

A Phase II Trial of a Surgical Protocol to Decrease the Incidence of Wound Complications in Obese Gynecologic Oncology Patients

Phase II Study of Bevacizumab and Pemetrexed for Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Related publications

Phase II Trial of Nab-Paclitaxel in the Treatment of Recurrent or Persistent Advanced Cervix Cancer: A Gynecologic Oncology Group Study

Implementation of a Restrictive Blood Transfusion Protocol in a Gynecologic Oncology Service

A Phase II Evaluation of Nintedanib (BIBF-1120) in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

516: Does the Alexis O-Ring Wound Retractor Decrease Surgical Blood Loss: A Secondary Analysis of a Randomized Controlled Trial

Supplemental Parenteral Nutrition in Critically Ill Patients: A Study Protocol for a Phase II Randomised Controlled Trial

A Phase II Evaluation of Lapatinib in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study

Access to Quality Gynecologic Oncology Care: A Work in Progress

Perioperative Hypothermia and Incidence of Surgical Wound Infection: A Bibliographic Study

Phase II Evaluation of Dasatinib in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study